相关实验视频
Updated: Jun 13, 2025

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.5K
针对 antracycline 心脏毒性的心脏保护策略
Andrea Moreno-Arciniegas1, Laura Cádiz1, Carlos Galán-Arriola1,2
1Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
Basic research in cardiology
|September 9, 2024
概括
抗癌疗法,如 antracyclines 可能会损害心脏. 研究正在探索心脏保护策略,以预防这种心脏毒性并改善癌症幸存者的生活质量.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于治疗的进步,癌症的生存率正在增加.
- 癌症疗法,特别是人环素,具有显著的心血管风险.
- 癌症和心血管疾病之间存在共同的风险因素和机械相互作用.
研究的目的:
- 审查当前和新兴的心脏保护策略,以防止癌症治疗诱导的心脏毒性.
- 突出了解和缓解人环素心脏毒性的挑战.
- 改善癌症幸存者的长期生活质量.
主要方法:
- 审查有关心脏保护剂和策略的现有文献.
- 由于其流行程度和影响,重点关注 antracycline 的心脏毒性.
- 在识别机制,目标和诊断工具方面分析挑战.
主要成果:
- 人环素被广泛使用,但具有相当大的心脏毒性潜力.
- 心脏毒性影响可能是暂时的或不可逆转的,影响幸存者.
- 开发心脏保护疗法对于管理长期影响至关重要.
结论:
- 有效的心脏保护对于减轻癌症治疗对心血管的影响至关重要.
- 需要进一步的研究来阐明机制,并开发有针对性的疗法.
- 改善的诊断是必要的,以早期检测心脏毒性.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
398
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
398
Heart Failure Drugs: Inotropic Agents
543
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
543
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
464
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
464
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
Exercise and Cardiovascular Response
746
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
746
Antianginal Drugs: Nitrates and β-Blockers
543
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
543

